Journal article

Treatment of bipolar depression

Michael Berk, Lesley Berk, Christopher G Davey, Steven Moylan, Francesco Giorlando, Ajeet B Singh, Harish Katra, Seetal Dodd, Gin S Malhi

Medical Journal of Australia | AUSTRALASIAN MED PUBL CO LTD | Published : 2013

Grants

Funding Acknowledgements

Lesley Berk acknowledges the National Health and Medical Research Council (NHMRC) for funding her PhD scholarship.Michael Berk has received grant or research support from Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Organon, Novartis, Mayne Pharma and Servier; has been a speaker for AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen-Cilag, Lundbeck, Merck, Pfizer, Sanofi-Synthelabo, Servier, Solvay and Wyeth; and served as a consultant to AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen-Cilag, Lundbeck and Servier. Francesco Giorlando has received grant or research support from AstraZeneca and Pfizer. Ajeet Singh has received grant or research support from Healthscope Molecular and Pfizer; and has been a speaker for AstraZeneca, Eli Lilly, Lundbeck and Pfizer. Harish Kalra has been a speaker for Eli Lilly and Pfizer. Seetal Dodd has received grant or research support from Bristol-Myers Squibb, Eli Lilly, Novartis, Mayne Pharma and Servier; and has been a speaker and served as a consultant for Eli Lilly.